Merck results beat expectations despite a big drop in sales of Covid antiviral treatment
Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for the first quarter beat Wall Street's expectations.
LocalNews
0
80
Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for the first quarter beat Wall Street's expectations.
